ZimVie (ZIMV) Set to Announce Quarterly Earnings on Wednesday

ZimVie (NASDAQ:ZIMV) will post its quarterly earnings results after the market closes on Wednesday, October 30th. ZimVie has set its FY 2024 guidance at 0.550-0.700 EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.

ZimVie (NASDAQ:ZIMV) last posted its earnings results on Thursday, August 1st. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.04). The business had revenue of $116.81 million for the quarter. ZimVie had a positive return on equity of 2.21% and a negative net margin of 63.84%. During the same period last year, the firm posted $0.17 EPS.

ZimVie Stock Performance

ZIMV stock opened at $13.87 on Monday. The business has a 50 day moving average price of $16.12 and a 200 day moving average price of $16.89. ZimVie has a fifty-two week low of $6.52 and a fifty-two week high of $22.40. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.43 and a current ratio of 1.94.

Insider Activity

In related news, major shareholder Camber Capital Management Lp sold 525,000 shares of the company’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $17.71, for a total transaction of $9,297,750.00. Following the transaction, the insider now owns 2,725,000 shares of the company’s stock, valued at $48,259,750. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 5.02% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC boosted their target price on ZimVie from $20.00 to $23.00 and gave the company a “buy” rating in a report on Friday, August 2nd.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.